2025. We offer detailed analysis at the sub-category level, as well as company-specific discussions, including Outperform rated WEED, TLRY, and TPB. Cowen Research 646 562 1330 [email protected] Vivien Azer 646 562 1351 [email protected] Equity Research Cannabis Suelu! SI odes Siu, OND “pelgiyoid

is, or will be related, directly or indirectly, to the specific recommendations or views expressed in this report. Important Disclosures Relating to Cowen Research Cowen and Company, LLC and or its affiliates make a market in the stock of GW Pharmaceuticals Plc, Tilray, Turning Point Brands and Canopy Growth Corp